Skip to content
Toggle navigation
About us
Our Technology
Healthcare Professionals
Investors
News
Contact us
Keyword search
News
Toggle navigation
OncoSil Medical in the news
Archived news
Our Team
ONCOSIL MEDICAL IN THE NEWS
Biotech Daily
Dr Boreham’s Crucible: OncoSil Medical
Read more
Biotechdispatch
OncoSil approval for the treatment of pancreatic cancer
Read more
Bioworld
Oncosil Wins CE mark, Breakthrough Designation for Pancreatic Cancer Device
Read more
Smallcaps
OncoSil Medical Obtains CE Mark and Breakthrough Device Designation for its Pancreatic Tumour Isotope
Read more
Finfeed
OncoSil™ Receives CE Marketing Approval
Read more
Finfeed
OncoSil Granted FDA Breakthrough Device Designation
Read more
The Market Herald
OncoSil Medical’s (ASX:OSL) Device Granted Breakthrough Designation by FDA
Read more
Finfeed
OncoSil on Verge of CE Mark Approval
Read more
Next Biotech
ASX MedTech Junior Displays Promise for Pancreatic Cancer Patients
Read more
We are currently in the process of updating our website.
Please contact us using the email address below for any information.
info@oncosil.com.au
Please
click here
to access the Oncosil Medical privacy policy
